Univariate Analysis for CMV Disease and Infection
. | (A) Univariate Analysis for CMV Disease . | (B) Univariate Analysis for CMV Infection . | ||||
---|---|---|---|---|---|---|
OR . | P Value . | 95% CI . | OR . | P Value . | 95% CI . | |
CD34 selection | 6.62 | <.001 | 2.3-19.0 | 2.69 | .04 | 1.0-7.0 |
Age at transplant | 1.99 | .18 | 0.7-5.4 | 1.47 | .28 | 0.7-3.0 |
No. of CD34 cells/kg infused | ||||||
>5 and <8.56 × 106 | 2.15 | .18 | 0.7-6.6 | 0.83 | .66 | 0.4-1.9 |
≥8.56 × 106 | 0.39 | .26 | 0.1-2.1 | 0.93 | .87 | 0.4-2.2 |
Underlying disease | 1.95 | .19 | 0.7-5.3 | 1.98 | .06 | 1.0-4.1 |
TBI conditioning regimen | 0.98 | .98 | 0.3-3.6 | 1.56 | .28 | 0.7-3.5 |
Steroid use | 1.54 | .40 | 0.6-4.2 | 3.00 | .003 | 1.5-6.1 |
. | (A) Univariate Analysis for CMV Disease . | (B) Univariate Analysis for CMV Infection . | ||||
---|---|---|---|---|---|---|
OR . | P Value . | 95% CI . | OR . | P Value . | 95% CI . | |
CD34 selection | 6.62 | <.001 | 2.3-19.0 | 2.69 | .04 | 1.0-7.0 |
Age at transplant | 1.99 | .18 | 0.7-5.4 | 1.47 | .28 | 0.7-3.0 |
No. of CD34 cells/kg infused | ||||||
>5 and <8.56 × 106 | 2.15 | .18 | 0.7-6.6 | 0.83 | .66 | 0.4-1.9 |
≥8.56 × 106 | 0.39 | .26 | 0.1-2.1 | 0.93 | .87 | 0.4-2.2 |
Underlying disease | 1.95 | .19 | 0.7-5.3 | 1.98 | .06 | 1.0-4.1 |
TBI conditioning regimen | 0.98 | .98 | 0.3-3.6 | 1.56 | .28 | 0.7-3.5 |
Steroid use | 1.54 | .40 | 0.6-4.2 | 3.00 | .003 | 1.5-6.1 |